Herantis Pharma Oyj HRTIS.HE Stock
1.4 EUR
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Finland
Exchange
Helsinki
Market Cap
28.22M EUR
LOW - HIGH [24H]
1.4
-
1.43 EUR
VOLUME [24H]
3.39K EUR
{{ volume }}
P/E Ratio
70.00
Earnings per share
0.02 EUR
Herantis Pharma Oyj Price Chart
Herantis Pharma Oyj HRTIS.HE Financial and Trading Overview
| Herantis Pharma Oyj stock price | 1.4 EUR |
| Previous Close | 1.99 EUR |
| Open | 2.05 EUR |
| Bid | 1.94 EUR x N/A |
| Ask | 2.01 EUR x N/A |
| Day's Range | 1.93 - 2.05 EUR |
| 52 Week Range | 1.48 - 3.04 EUR |
| Volume | 664 EUR |
| Avg. Volume | 3.74K EUR |
| Market Cap | 32.64M EUR |
| Beta (5Y Monthly) | 0.468582 |
| PE Ratio (TTM) | 2.8805969 |
| EPS (TTM) | 0.02 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.1 EUR |
HRTIS.HE Valuation Measures
| Enterprise Value | 32.1M EUR |
| Trailing P/E | 2.8805969 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.016 |
Trading Information
Herantis Pharma Oyj Stock Price History
| Beta (5Y Monthly) | 0.468582 |
| 52-Week Change | 28.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.04 EUR |
| 52 Week Low | 1.48 EUR |
| 50-Day Moving Average | 2.06 EUR |
| 200-Day Moving Average | 2.04 EUR |
HRTIS.HE Share Statistics
| Avg. Volume (3 month) | 3.74K EUR |
| Avg. Daily Volume (10-Days) | 1.77K EUR |
| Shares Outstanding | 16.91M |
| Float | 11.15M |
| Short Ratio | N/A |
| % Held by Insiders | 32.99% |
| % Held by Institutions | 32.74% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -71.39% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -7992762 EUR |
| Net Income Avi to Common (ttm) | -9324225 EUR |
| Diluted EPS (ttm) | 0.67 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.99M EUR |
| Total Cash Per Share (mrq) | 0.35 EUR |
| Total Debt (mrq) | 4.6M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.277 |
| Book Value Per Share (mrq) | -0.004 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8943913 EUR |
| Levered Free Cash Flow (ttm) | -4822095 EUR |
Profile of Herantis Pharma Oyj
| Country | Finland |
| State | N/A |
| City | Espoo |
| Address | Bertel Jungin Aukio 1 |
| ZIP | 02600 |
| Phone | 358 9222 1195 |
| Website | https://herantis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic molecule developed based on the active site of the parent CDNF protein for the treatment of PD and other neurodegenerative diseases; and recombinant human CDNF protein. The company was incorporated in 2008 and is based in Espoo, Finland.
Q&A For Herantis Pharma Oyj Stock
What is a current HRTIS.HE stock price?
Herantis Pharma Oyj HRTIS.HE stock price today per share is 1.4 EUR.
How to purchase Herantis Pharma Oyj stock?
You can buy HRTIS.HE shares on the Helsinki exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Herantis Pharma Oyj?
The stock symbol or ticker of Herantis Pharma Oyj is HRTIS.HE.
Which industry does the Herantis Pharma Oyj company belong to?
The Herantis Pharma Oyj industry is Biotechnology.
How many shares does Herantis Pharma Oyj have in circulation?
The max supply of Herantis Pharma Oyj shares is 20.16M.
What is Herantis Pharma Oyj Price to Earnings Ratio (PE Ratio)?
Herantis Pharma Oyj PE Ratio is 70.00000000 now.
What was Herantis Pharma Oyj earnings per share over the trailing 12 months (TTM)?
Herantis Pharma Oyj EPS is 0.02 EUR over the trailing 12 months.
Which sector does the Herantis Pharma Oyj company belong to?
The Herantis Pharma Oyj sector is Healthcare.
Herantis Pharma Oyj HRTIS.HE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Finland EUR PI FNFIEURPI | 1308.52 EUR 1430.39 USD |
-0.14
|
— — | — — | — — | — - | — — |
| First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
| First North Finland EUR GI FNFIEURGI | 1517.82 EUR 1659.18 USD |
+0.12
|
— — | — — | — — | — - | — — |
| First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}